Chirayu Chokshi

The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

Parvez Vora, Chitra Venugopal, Sabra K. Salim et al. · Cell stem cell · 2020 · 179 citations · Full text

Neuro-oncology, Rational Development, Immunology +6

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma

William D. Gwynne, Yujin Suk, Stefan Custers et al. · Cancer Cell · 2022 · 85 citations

Oncology, Cancer-selective Metabolic Vulnerabilities, Oncogenic Agent +5

An Intrinsically Disordered APLF Links Ku, DNA-PKcs, and XRCC4-DNA Ligase IV in an Extended Flexible Non-homologous End Joining Complex

Michal Hammel, Yaping Yu, Sarvan Kumar Radhakrishnan et al. · Journal of Biological Chemistry · 2016 · 74 citations · Full text

Biochemistry, Protein Assembly, Protein Folding +7

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment

Mathieu Seyfrid, William Maich, Muhammad Vaseem Shaikh et al. · Journal for ImmunoTherapy of Cancer · 2022 · 74 citations · Full text

Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi, Parvez Vora, Chitra Venugopal et al. · Cancer Research · 2018 · 57 citations